Literature DB >> 23808892

Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model.

Sung Gon Shim1, Dae Won Jun, Eun Kyung Kim, Waqar Khalid Saeed, Kang Nyeong Lee, Hang Lak Lee, Oh Young Lee, Ho Soon Choi, Byung Chul Yoon.   

Abstract

BACKGROUND AND AIM: Several epidemiological studies have shown that coffee intake attenuates the progression of liver fibrosis; however, the mechanism is unclear. AIMS: We investigated the direct effects of caffeine on hepatic stellate cells (HSCs) and assessed whether caffeine attenuated intrahepatic fibrosis in rat model of liver cirrhosis.
METHODS: Human hepatic stellate cell line, an immortalized human HSCs line, was used in in vitro assay system. Cell migration and proliferation were assessed in presence of various caffeine concentrations (0, 1, 5, and 10 mmol), and levels of procollagen type Ic and α-smooth muscle actin (α-SMA) were measured by Western blot. Severity of liver inflammation and fibrosis were compared between thioacetamide-treated rats with and without caffeine supplementation.
RESULTS: Caffeine increased HSCs apoptosis and intracellular F-actin and cyclic adenosine monophosphate expression. Caffeine also inhibited procollagen type Ic and α-SMA expression in a dose- and time-dependent manner. In rat model, caffeine decreased periportal inflammation, levels of inflammatory cells (1.4 ± 0.52 vs 2.6 ± 0.46, P < 0.05), and fibrosis (2.1 ± 0.35 vs 2.9 ± 0.84, P < 0.05). Transforming growth factor-β and α-SMA expressions were also reduced by caffeine.
CONCLUSION: Caffeine attenuates the progression of liver fibrosis by inhibiting HSCs adhesion and activation.
© 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  TGF-β; adhesion; caffeine; liver fibrosis; stellate cell

Mesh:

Substances:

Year:  2013        PMID: 23808892     DOI: 10.1111/jgh.12317

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  25 in total

1.  Coffee provides a natural multitarget pharmacopeia against the hallmarks of cancer.

Authors:  François Gaascht; Mario Dicato; Marc Diederich
Journal:  Genes Nutr       Date:  2015-11-17       Impact factor: 5.523

2.  Coffee: a panacea or snake oil for the liver?

Authors:  Radhika Kumari; W Ray Kim
Journal:  Clin Gastroenterol Hepatol       Date:  2014-04-24       Impact factor: 11.382

3.  Inverse associations of total and decaffeinated coffee with liver enzyme levels in National Health and Nutrition Examination Survey 1999-2010.

Authors:  Qian Xiao; Rashmi Sinha; Barry I Graubard; Neal D Freedman
Journal:  Hepatology       Date:  2014-10-30       Impact factor: 17.425

4.  The effects of caffeine on wound healing.

Authors:  Nkemcho Ojeh; Olivera Stojadinovic; Irena Pastar; Andrew Sawaya; Natalie Yin; Marjana Tomic-Canic
Journal:  Int Wound J       Date:  2014-07-08       Impact factor: 3.315

Review 5.  Food components with antifibrotic activity and implications in prevention of liver disease.

Authors:  Minkyung Bae; Young-Ki Park; Ji-Young Lee
Journal:  J Nutr Biochem       Date:  2017-11-16       Impact factor: 6.048

6.  How does coffee prevent liver fibrosis? Biological plausibility for recent epidemiological observations.

Authors:  Jonathan A Dranoff; Jordan J Feld; Elise G Lavoie; Michel Fausther
Journal:  Hepatology       Date:  2014-05-27       Impact factor: 17.425

Review 7.  Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.

Authors:  Gülsüm Özlem Elpek
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 8.  Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials.

Authors:  Shira Zelber-Sagi; Justyna Godos; Federico Salomone
Journal:  Therap Adv Gastroenterol       Date:  2016-03-17       Impact factor: 4.409

Review 9.  Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step.

Authors:  Ralf Weiskirchen
Journal:  Front Pharmacol       Date:  2016-01-07       Impact factor: 5.810

Review 10.  Association between caffeine consumption and nonalcoholic fatty liver disease: a systemic review and meta-analysis.

Authors:  Huafeng Shen; Andrea C Rodriguez; Ashok Shiani; Seth Lipka; Ghulamullah Shahzad; Ambuj Kumar; Paul Mustacchia
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.